Synmosa Biopharma Corporation (4114.TWO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Chih-Hui Lin | Chairman, GM, Managerial Officer & President | 4.71M | -- | 1983 |
| Mr. Hong-Qin Bai | Senior VP & Finance Officer | 3.5M | -- | -- |
| Ms. Jia-Xin Zhang | Senior Vice President | 3.02M | -- | -- |
| Mr. Sheng-Ren Yang | Senior Vice President | 3.14M | -- | -- |
| Liyu Huang | Chief Financial Officer | -- | -- | -- |
| Ching-Hua Tsao | Accounting Officer | -- | -- | -- |
| Mr. Zen Young | Vice President of Sales - HP, Marketing & Medical | -- | -- | -- |
Synmosa Biopharma Corporation
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. The company offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company also provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, sex hormones, and other forms. In addition, it offers contract manufacturing services. The company also exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, and other countries. Synmosa Biopharma Corporation was incorporated in 1980 and is headquartered in Taipei, Taiwan.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
August 9, 2024 at 12:00 AM UTC
Ex-Dividend Date